p-38 kinase inhibitors

Details for Australian Patent Application No. 2004261589 (hide)

Owner Novartis AG

Inventors Lang, Hengyuan; Fang, Yunfeng; Lan, Jiong

Agent Davies Collison Cave

Pub. Number AU-B-2004261589

PCT Pub. Number WO2005/012241

Priority 60/490,096 25.07.03 US

Filing date 23 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 22 May 2008

International Classifications

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/74 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/82 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/88 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 249/08 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 271/10 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

9 February 2006 PCT application entered the National Phase

  PCT publication WO2005/012241 Priority application(s): WO2005/012241

22 May 2008 Application Accepted

  Published as AU-B-2004261589

18 September 2008 Standard Patent Sealed

17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004261591-Imidazo-pyrimidines and triazolopyrimidines: benzodiazepine receptor ligands

2004261587-Substituted pyridones and pyrimidinones with antiinflammatory properties